An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)
NCT01759264
·
clinicaltrials.gov ↗
COMPLETED
Status
101
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Sponsor
AbbVie (prior sponsor, Abbott)